Financials
- Financial year
- 2025
- Total assets
- €419,914
- Profit
- €61
- Solvency
- -50.6%
Total assets▲ 183%
Net result
20202025
BIOCYTE BENELUX
InactiveOverview
Activity
“La commercialisation de produits diététiques, l'import-export et la vente par correspondance de ces produits” (deed in French)
From the articles, 15 activitiesNo NACE code in the KBO yet
Size
€419,914total assets 2025
- Staff
- 1 FTE
- Equity
- -€212,588
- Profit
- €61
Financial health
Inactive: no score
Structure
- Parent
- ixX pharma · 100%
4 of 7 deeds read
SignalsneutralFiled after the deadlineShow the evidence
Signals
1 signal.
neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-10-2026, 76 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 6 filingsDeviation from the deadline
2025
76 days late
2024
50 days late
2023
33 days early
2022
48 days early
2021
23 days early
2020
12 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 6 accounts on average 2 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · abbreviated…
- Resignations & appointments · RestructuringResignation: Benjamin FRANCQ (director) ·…
- RestructuringMerger · Declaration
Key points
By topic
Board & ownership
- Parent
- ixX pharma · 100%
Network & group
- Group
- Bon Topco
- Mergers and asset contributions
- 1
Timeline
- Events
- 12
- Since
- 2021
- 04-06-2026Restructuring
- 31-12-2025Back to profit
- 19-09-2025Annual accounts filed
Company details
- Legal form
- Private limited company
- Year ends
- 31-12
- Peppol
- Still in the Peppol directory
Articles of association
- Provisions read
- 4
- Purpose
- “La commercialisation de produits diététiques, l'import-export et la vente par…” (deed in French)
Key facts about BIOCYTE BENELUX
- What is the company number of BIOCYTE BENELUX?
- 0730.898.265. In Belgium the VAT number is the company number with BE in front: BE 0730.898.265.
- What is the legal form of BIOCYTE BENELUX?
- Private limited company (BV).
- Is BIOCYTE BENELUX still active?
- No. BIOCYTE BENELUX is inactive in the KBO register.Company details
- How many employees did BIOCYTE BENELUX have?
- On average 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of BIOCYTE BENELUX?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
- Is BIOCYTE BENELUX profitable?
- In financial year 2025, BIOCYTE BENELUX made a profit of €61.
- Where can I find the annual accounts of BIOCYTE BENELUX?
- BIOCYTE BENELUX filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
Companies related to BIOCYTE BENELUX
Parent and group
Go further with this company
What became of the directors' other companies?Supplier due diligence Who ran this company, and where was it based, on a given date before it ended?Company as of a date
Investigating this company? Keep it with today's facts in a case file.